Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity. (Q51031693)

27 March 2018

title

Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity. (English)

1 reference

27 March 2018

0 references

John H Carra

1

1 reference

27 March 2018

Robert W Wannemacher

2

1 reference

27 March 2018

Ralph F Tammariello

3

1 reference

27 March 2018

Changhong Y Lindsey

4

1 reference

27 March 2018

Richard E Dinterman

5

1 reference

27 March 2018

Rowena D Schokman

6

1 reference

27 March 2018

Leonard A Smith

7

1 reference

27 March 2018

language of work or name

English

0 references

publication date

26 March 2007

1 reference

27 March 2018

published in

Vaccine

1 reference

27 March 2018

volume

25

1 reference

27 March 2018

issue

21

1 reference

27 March 2018

page(s)

4149-4158

1 reference

27 March 2018

Ricin. Mechanisms of cytotoxicity.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Immunological characteristics associated with the protective efficacy of antibodies to ricin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Monoclonal antibodies to ricin: in vitro inhibition of toxicity and utility as diagnostic reagents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Oligosaccharide side chains on human secretory IgA serve as receptors for ricin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Ricin: current understanding and prospects for an antiricin vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Finding a new vaccine in the ricin protein fold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Improved stability of a protein vaccine through elimination of a partially unfolded state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Attenuated total reflection infrared spectroscopy of proteins and lipids in biological membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Validation of ELISA for the determination of anti-ricin immunoglobulin G concentration in mouse sera.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

The use and misuse of FTIR spectroscopy in the determination of protein structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Enhanced prediction accuracy of protein secondary structure using hydrogen exchange Fourier transform infrared spectroscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Thermal stability of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

The role of the adsorption process for production and control combined adsorbed vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

A novel recombinant vaccine which protects mice against ricin intoxication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

A pilot clinical trial of a recombinant ricin vaccine in normal humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

A rapid, three-step process for the preformulation of a recombinant ricin toxin A-chain vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Adsorption of pepsin by aluminum hydroxide I: Adsorption mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Predicting the adsorption of proteins by aluminium-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Treatment of aluminium hydroxide adjuvant to optimize the adsorption of basic proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Free energy determinants of binding the rRNA substrate and small ligands to ricin A-chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Immunity in response to particulate antigen-delivery systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Spectroscopic characterization of antibodies adsorbed to aluminium adjuvants: correlation with antibody vaccine immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Association between immunogenicity and adsorption of a recombinant Streptococcus pneumoniae vaccine antigen by an aluminum adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

Crystallographic refinement of ricin to 2.5 A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.03.011

10.1016/J.VACCINE.2007.03.011

7 January 2021

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018